Effect of acetazolamide on the insulin response to intravenous administration of secretin.
D000086:Acetazolamide / Q000494:pharmacology*; D000941:Antigens; D001639:Bicarbonates / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism; D002908:Chronic Disease; D004357:Drug Synergism; D004386:Duodenum; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005990:Glycerol / Q000097:blood; D006801:Humans; D001239:Inhalation; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007419:Intestinal Secretions / Q000378:metabolism; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D010182:Pancreatic Diseases / Q000209:etiology; D010189:Pancreatic Juice / Q000378:metabolism; D012633:Secretin / Q000008:administration & dosage / Q000494:pharmacology*
D000941:Antigens; D001639:Bicarbonates; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D012633:Secretin; D000086:Acetazolamide; D005990:Glycerol